Author Archive: BIOtechNOW Editor

From Bench to Bedside in a Bioeconomy

lab_tech02-btn

By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program when the closing panel reinforces the opening speaker. Boston University President Robert Brown kicked off the afternoon at the Translational Research Forum at the 2012 BIO International Convention by showing how the old linear model of product development crafted after World War II no longer applies. The closing industry panel aptly remarked that a struggling economy has brought the public and private Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Dr. Lewis Sullivan Leads Panel on Diversity in Education and the Biotech Workplace

Luis Sullivan

This year the Diversity Summit at the 2012 BIO International Convention focused on the importance of recruiting and fostering a diverse workforce in the biotechnology field. Past Diversity Summits have focused on diversity in research and clinical trials, but experts have found that it can be challenging to develop new treatments and cures without a diverse workforce pursuing these discoveries. For panelists as well as those in the audience, the need to bring minorities into Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Measuring the Impact of Innovation

USPTO

By Joe Allen, President, Allen and Associates It’s always an indication of interest and importance in a topic when a panel draws a standing room only crowd. And that was the case with the Measuring the Impacts of Innovation: What is the Future of Tech Transfer? session at the 2012 BIO International Convention. The panel focused on the need to help policy makers, institutions and the public identify appropriate measures for how publicly funded R&D Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Biotech Companies are Bringing Innovation to Global Health

Don Joseph

By Don Joseph, CEO, BIO Ventures for Global Health In March, we at BIO Ventures for Global Health (BVGH) released a report, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape, which showed that small- to medium-sized biotechnology companies are participating in a high percentage (41 percent) of projects targeting neglected diseases of the developing world. The findings of this report were surprising, given the financial risks these companies Read More >

Events  |  2 Comments  |  Email This Post
Tags: , , , ,

Out and About in Boston During the BIO International Convention

Bob Coughlin

By Bob Coughlin, President & CEO, MassBio You will surely be very busy during your time at the 2012 BIO International Convention but you might find you have a little downtime to explore Boston. If you’re looking for suggestions, here are some of my favorite places to see, things to do, and restaurants to enjoy in the city. First of all, let me mention the Red Sox are home… Fenway Park, the oldest Major League Baseball Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,